Access to Medicines

Prohibition and restriction of manufacture, sale and distribution of Fixed Dose Combinations (FDCs)

Posted in Access to Medicines | Leave a comment

Health groups welcome price fixation of cardiac stents by NPPA

Health groups welcomed the notification by the National Pharmaceutical Pricing Authority (NPPA) of ceiling prices for coronary stents. The NPPA has notified a ceiling price for Drug Eluting Stents (DES) at Rs.29,600 and for Bare Metal Stents (BMS) at Rs.7,260 under the provisions of paragraph 19 of the Drugs Prices Control Order, 2013…read full statement […]

Posted in Access to Medicines | Comments Off on Health groups welcome price fixation of cardiac stents by NPPA

Jan Swasthya Abhiyan Expresses Concern and Shock at the Lifting of the ban order on 344 FDCs

The Jan Swasthya Abhiyan (JSA) expresses its deepest concern and shock at the verdict of the Delhi High Court, lifting the ban imposed on 344 Fixed Dose Combinations (FDCs) of drugs by the Government a few months back. This is a huge setback to efforts aimed at bringing a semblance of order into the absolute […]

Posted in Access to Medicines | Comments Off on Jan Swasthya Abhiyan Expresses Concern and Shock at the Lifting of the ban order on 344 FDCs

Ban on FDCs: Public Health Must Prevail Over Corporate Profits

The Jan Swasthya Abhiyan compliments the Government for notifying a list of over 300 drug formulations, available as fixed‐dose combinations (FDCs) of two or more drugs, which are to be banned with immediate effect on the grounds of lack of “lack of therapeutic justification”. This is a long pending measure and needs to be followed […]

Posted in Access to Medicines | Comments Off on Ban on FDCs: Public Health Must Prevail Over Corporate Profits